HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Response to publications by Heyward W et al. and Kuan R et al.: Clinical and cost-effectiveness analyses, respectively, of hepatitis B vaccination-Heplisav™ compared with Engerix-B(®) vaccine in adults.

AuthorsMarc De Ridder, Desmond Curran, Geert Leroux-Roels
JournalVaccine (Vaccine) Vol. 33 Issue 28 Pg. 3161 (Jun 22 2015) ISSN: 1873-2518 [Electronic] Netherlands
PMID24892249 (Publication Type: Letter, Comment)
Chemical References
  • Hepatitis B Vaccines
Topics
  • Hepatitis B (prevention & control)
  • Hepatitis B Vaccines (economics, therapeutic use)
  • Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: